跳至主要内容
临床试验/NL-OMON49468
NL-OMON49468尚未招募不适用

Exploring the mechanism of action of low-dose glucocorticoids: a study of oral versus parenteral glucocorticoids. - GC-first-pass

Reade0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Reumatoid arthritis, polymyalgia rheumatica or psoriatic arthritis according
  • to the treating physician
  • -Elevated ESR (>=30 mm/h)

排除标准

  • Difficult to measure a decreased ESR
  • -Current or recent (<4 weeks previously) on any form of GC therapy, including
  • topical use
  • -For reumatoid arthritis and psoriatic arthritis patients, change of
  • antirheumatic medication (DMARDs, biologics) in the 4 weeks before the
  • -Known with other health conditions that can cause elevated ESR (e.g.
  • hematologic disorders, infections, multiple myeloma, monoclonal gammopathy etc.)
  • Risk of harm
  • -Active disease necessitating immediate (change of) treatment, according to
  • treating physician
  • -Unstable medical condition causing contra-indication for GC, according to
  • treating physician. For example active infection, unstable diabetes, malignant
  • hypertension, etc.
  • -Signs or symptoms of giant cell arteritis (according to the treating physician)
  • Unable or unwilling to provide informed consent

研究者

发起方
Reade

相似试验

Exploring the mechanism of action of low-dose... | 临床试验